Correlation Between Pmv Pharmaceuticals and Cyteir Therapeutics

Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Cyteir Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Cyteir Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pmv Pharmaceuticals and Cyteir Therapeutics, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Cyteir Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Cyteir Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Cyteir Therapeutics.

Diversification Opportunities for Pmv Pharmaceuticals and Cyteir Therapeutics

0.03

Correlation Coefficient

Pmv Pharmaceuticals  Cyteir Therapeutics

Significant diversification

The 3 months correlation between Pmv and Cyteir is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Cyteir Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyteir Therapeutics and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Cyteir Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyteir Therapeutics has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Cyteir Therapeutics go up and down completely randomly.

Pair Corralation between Pmv Pharmaceuticals and Cyteir Therapeutics

Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to under-perform the Cyteir Therapeutics. In addition to that, Pmv Pharmaceuticals is 1.05 times more volatile than Cyteir Therapeutics. It trades about -0.04 of its total potential returns per unit of risk. Cyteir Therapeutics is currently generating about 0.12 per unit of volatility. If you would invest  132.00  in Cyteir Therapeutics on September 4, 2024 and sell it today you would earn a total of  144.00  from holding Cyteir Therapeutics or generate 109.09% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	30.51%
Values	Daily Returns

Pmv Pharmaceuticals  vs.  Cyteir Therapeutics

Pmv Pharmaceuticals

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Pmv Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Pmv Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Cyteir Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cyteir Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Cyteir Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Pmv Pharmaceuticals and Cyteir Therapeutics

The main advantage of trading using opposite Pmv Pharmaceuticals and Cyteir Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Cyteir Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyteir Therapeutics will offset losses from the drop in Cyteir Therapeutics' long position.

The idea behind Pmv Pharmaceuticals and Cyteir Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.